Characteristics of Infections after BCMA-directed CAR-T cells therapy for Multiple Myeloma - a real-world analysis

Blood Adv. 2025 Jan 2:bloodadvances.2024015008. doi: 10.1182/bloodadvances.2024015008. Online ahead of print.
No abstract available